2021-01-04,"b'$EVLO $12.09 +0.03  +0.25%EDP1815 Atopic dermatitis Phase 1b data due 1Q 2021.\n$ARCT $43.38 -3.33  -7.13%LUNAR-COV19\nCOVID-19 vaccine Phase 2 trial to commence in Singapore. Interim data due early 2021. Phase 3 trial to commence 2Q 2021. Phase 1/2 data released December 28, 20'"
2021-01-03,b'@HighlineTrading @tlutri Reminds me of $tusk and $evlo. And a bigger version of $ncty'
2021-01-03,b'RT @BSchulz33868165: (5 of 6)\nMedia: +1.64%; 11 of 13 Up (&gt;=4%: $FLNT $ICLK)\nBio/Pharm: +1.52%; 48 of 72 Up (&gt;=4%: $DMTK $ALVR $NK $ACRS $O\xe2\x80\xa6'
2021-01-02,"b""$EVLO's Aroon indicator reaches into Uptrend on December 31, 2020. View odds for this and other indicators: https://t.co/pp0fEvGoPz #EveloBiosciences #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/6TMigTxaAw"""
2021-01-01,b'$evlo what a nice bullish flag. Hard to be bearish on this one short term. No position. https://t.co/sCJ7G3sGxU'
2021-01-01,"b""$EVLO's Aroon indicator reaches into Uptrend on December 30, 2020. View odds for this and other indicators: https://t.co/DeJQ5JKFlz #EveloBiosciences #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/eeFGSGBHLX"""
2020-12-31,b'Evelo Biosciences Inc. Shares Close in on 52-Week High - Market Mover https://t.co/3VhRkO98bs $EVLO #stockmarket #kwhenfinance'
2020-12-31,"b""RT @Stockonomist: @MissPond I'm hoping and praying that $EVLO early success in Phase I clinical trials of their oral microbiome therapy for\xe2\x80\xa6"""
2020-12-31,"b""@MissPond I'm hoping and praying that $EVLO early success in Phase I clinical trials of their oral microbiome therapy for atopic dermatitis will continue to show efficacy in later stage trials\n\nhttps://t.co/KQKp6U8cCW"""
2020-12-30,b'(5 of 6)\nBio/Pharm: +1.72%; 49 of 72 Up (&gt;=5%: $DMTK $ALVR $VCEL $SRRK $NK $EVLO $BCRX $APVO $TCON $TWST)\nMedia: +1.69%; 11 of 13 Up (&gt;=5%: $FLNT)\nRetail: +1.54%; 27 of 40 Up (&gt;=5%: $BLNK $PDD $GRWG $JMIA)\nHealthcare: +1.46%; 36 of 48 Up (&gt;=5%: $OM $LUNG)'
2020-12-30,"b'Large Print $EVLO Size: 142466 Price: 12.06 Time: 1600 Amount: $1,718,139.96'"
2020-12-30,"b'JMP $EVLO bullish on EDP1815\xe2\x80\x99s opportunity in mild-to-moderate atopic dermatitis (AtD) believe shares continue to remain undervalued heading into next month, when full results, including itch- score, among other patient-reported outcomes biomarkers, will be presented.'"
2020-12-30,b'Top losers 12/29\n$CMT\n$CNST\n$COGT\n$CREX\n$CRSR\n$CSLT\n$CSPR\n$CSTL\n$CTRA\n$CVGI\n$CYCC\n$CYTH\n$DDD\n$DM\n$DPW\n$DRIO\n$DS\n$DXF\n$EDIT\n$EKSO\n$EQOS\n$ESGC\n$ETTX\n$EVGN\n$EVLO\n$EVOL\n$EXPR\n$FGF\n$FLNT\n$FTHM\n$GBS\n$GME\n$GP\n$GTIM\n$HGSH\n$HMHC\n$HYFM\n$HYRE\n$ID\n$IDEX\n$IDRA\n$IKT\n$IMAC\n$IMH\n$IMNM\n$INBX\n$INO'
2020-12-30,b'(5 of 6)\nMedia: +1.64%; 11 of 13 Up (&gt;=4%: $FLNT $ICLK)\nBio/Pharm: +1.52%; 48 of 72 Up (&gt;=4%: $DMTK $ALVR $NK $ACRS $ONVO $EVLO $IGMS $IDRA $SRRK)\nIndustrial: +1.51%; 23 of 26 Up (&gt;=4%: $SIF $GP)\nLeisure: +1.42%; 19 of 27 Up (&gt;=4%: $BILI $ZDGE $KBNT $LIVX)'
2020-12-30,"b'$EVLO JMP Securities Reiterates Buy Rating On Evelo Biosciences, Raises PT To $27 https://t.co/kPVRx2AWNB'"
2020-12-30,"b'Evelo shares undervalued into atopic dermatitis data, says JMP Securities\n$EVLO'"
2020-12-29,"b""It's not always up $ARCT, $EDIT, $PACB, $SYRS, $CSTL, $EVLO, $TBIO, $INSG https://t.co/Sye5yApiuQ"""
2020-12-28,b'RT @BSchulz33868165: (5 of 5)\nBio/Pharm: -2.62%; 17 of 75 Up (&gt;=4%: $EVLO $TCON $BEAM $MNKD)\nChina: -3.01%; 5 of 26 Up\nLeisure: -3.17%; 5 o\xe2\x80\xa6'
2020-12-28,b'RT @duke_pearson: [NASDAQ]\n52W-NewHigh\xe9\x8a\x98\xe6\x9f\x84/Health Care\n1: $MDNA \n2: $EVGN \n3: $XTLB \n4: $EPIX \n5: $DMAC \n6: $NTLA \n7: $EVLO \n8: $CRSP \n9: $NA\xe2\x80\xa6'
2020-12-28,b'(5 of 5)\nBio/Pharm: -2.62%; 17 of 75 Up (&gt;=4%: $EVLO $TCON $BEAM $MNKD)\nChina: -3.01%; 5 of 26 Up\nLeisure: -3.17%; 5 of 27 Up'
2020-12-28,b'[NASDAQ]\n52W-NewHigh\xe9\x8a\x98\xe6\x9f\x84/Health Care\n1: $MDNA \n2: $EVGN \n3: $XTLB \n4: $EPIX \n5: $DMAC \n6: $NTLA \n7: $EVLO \n8: $CRSP \n9: $NARI \n10: $CLLS \n\nhttps://t.co/88EAFrvqsg\n\n2020/12/29 6:10:49'
2020-12-28,"b'20 day high in leading stocks scan $MARA, $RIOT, $BTBT, $SOL, $IEA, $CLSK, $MWK, $EVGN, $LAKE, $EVLO #stocks #trading https://t.co/J7ITcPXIam'"
2020-12-28,b'13:48 New 52wk Highs: $CSGP $EVLO'
2020-12-28,b'New 52 Week High today: $EVLO $HELE $QTUM $EBLU $CALF $EQS $GDVD $XOMA ... https://t.co/4Iw0QeR3p8'
2020-12-28,b'(4 of 5)\nBio/Pharm: -0.38%; 29 of 75 Up (&gt;=4%: $NTLA $TCON $EDIT $CLLS $SGMO $BEAM $EVLO $FPRX $CMRX $CSTL $CRSP)\nTechSvcs: -0.61%; 3 of 20 Up (&gt;=4%: $MARA $BCOV)\nHealthcare: -0.82%; 20 of 49 Up (&gt;=4%: $RVP $LGVW $PACB)\nConsumer: -0.94%; 13 of 38 Up (&gt;=4%: $FUV $STKL $RIDE)'
2020-12-28,b'$DMTK $TCRR $OVID $MRNA $SILK $TBIO $MYOV $AXSM $HALO $TFFP $VAPO $RCKT $TWST $TGTX $CRDF $EVLO  There More Room To Run For These Biotech Stock Picks That Delivered Triple Digit Gains?https://t.co/Ovf6SHVoAL'
2020-12-28,b'Most Volatile 12/24\n$EMAN\n$NOVS\n$TARS\n$THCB\n$BIVI\n$IPWR\n$ACRS\n$DQ\n$TRIT\n$MWK\n$SNCR\n$SRNE\n$EVOL\n$LGVW\n$FLNT\n$ELOX\n$TMDI\n$GRTS\n$EPIX\n$CATB\n$ABEO\n$KOS\n$FIII\n$TSHA\n$SNES\n$FEYE\n$NVUS\n$GME\n$EVLO\n$HARP\n$MARK\n$BTBT\n$UUUU\n$CRHM\n$IMAC\n$HOTH\n$OBLN\n$APRE\n$ONCR\n$CLSK\n$MDGS\n$ALVR\n$LGF-B\n$SOL'
2020-12-27,b'Bilo Selhi Crypto &amp; Stock Alert subscribers are reporting success https://t.co/mmLY3mYytj $TNXP $AQMS $BIOL $ENG $ALPP $SLDB $SLS $RVP $AVXL $SOL $VUZI $IMMP $CCM $EVLO $POLA $LDL $MCEP $MCF $QUAD $CARV $SNOA'
2020-12-27,b'$EVLO https://t.co/T189cHCL3G Evelo Biosciences Inc The automated equity analyst has forecasted this equity value will go south in the coming week and has a negative long term outlook #business #cryptocurrency #startup'
2021-01-07,b'RT @BlogShrey: #DDDD $LOAC $LBPS\n\nEvelo Biosciences $EVLO is worth c. $600m on the NASDAQ.\n\nIt operates in the same sector as 4d Pharma.\n\n4\xe2\x80\xa6'
2021-01-07,b'RT @BlogShrey: #DDDD $LOAC $LBPS\n\nEvelo Biosciences $EVLO is worth c. $600m on the NASDAQ.\n\nIt operates in the same sector as 4d Pharma.\n\n4\xe2\x80\xa6'
2021-01-07,b'RECAP 1/7 +Pos Comments:\n$AMRN + Cowen\n$DDD + JPM\n$EVLO + BMO\n$PCRX + RBC \n$LMND + Motley Fool'
2021-01-07,b'RT @BlogShrey: #DDDD $LOAC $LBPS\n\nEvelo Biosciences $EVLO is worth c. $600m on the NASDAQ.\n\nIt operates in the same sector as 4d Pharma.\n\n4\xe2\x80\xa6'
2021-01-07,b'RT @BlogShrey: #DDDD $LOAC $LBPS\n\nEvelo Biosciences $EVLO is worth c. $600m on the NASDAQ.\n\nIt operates in the same sector as 4d Pharma.\n\n4\xe2\x80\xa6'
2021-01-07,b'RT @BlogShrey: #DDDD $LOAC $LBPS\n\nEvelo Biosciences $EVLO is worth c. $600m on the NASDAQ.\n\nIt operates in the same sector as 4d Pharma.\n\n4\xe2\x80\xa6'
2021-01-07,b'RT @BlogShrey: #DDDD $LOAC $LBPS\n\nEvelo Biosciences $EVLO is worth c. $600m on the NASDAQ.\n\nIt operates in the same sector as 4d Pharma.\n\n4\xe2\x80\xa6'
2021-01-07,b'RT @BlogShrey: #DDDD $LOAC $LBPS\n\nEvelo Biosciences $EVLO is worth c. $600m on the NASDAQ.\n\nIt operates in the same sector as 4d Pharma.\n\n4\xe2\x80\xa6'
2021-01-07,b'Evelo Biosciences expands EDP1815 mid-stage trial to atopic dermatitis $EVLO https://t.co/hu4dQpYWN5'
2021-01-07,b'RT @BlogShrey: #DDDD $LOAC $LBPS\n\nEvelo Biosciences $EVLO is worth c. $600m on the NASDAQ.\n\nIt operates in the same sector as 4d Pharma.\n\n4\xe2\x80\xa6'
2021-01-07,"b'#DDDD $LOAC $LBPS\n\nEvelo Biosciences $EVLO is worth c. $600m on the NASDAQ.\n\nIt operates in the same sector as 4d Pharma.\n\n4d have a far greater pipeline, manufacturing capability, intellectual property estate (1000+ patents) and collab. with Merck $MRK.\n\nThey are worth c. $200m.'"
2021-01-07,b'12:18 New 52wk Highs: $EVLO $LECO'
2021-01-07,b'@geoffreywells @jfais20 I feel $MCRB is pricing in a lot of success at $3bn Mkt Cap vs $1.7bn Market Opportunity in c.diff \n\nvs $EVLO and $LOAC with Market Caps a fraction of addressable markets \n\nSPAC $LOAC will take over 4D and immediately have Big Pharma $MRK as shareholder and partner'
2021-01-07,b'@jfais20 $LOAC and $EVLO in #Microbiome ?'
2021-01-07,b'$EVLO Evelo Biosciences Expands Clinical Programs and Provides 2021 Guidance on Key Milestones https://t.co/6WODvhKm0N'
2021-01-07,b'Evelo Biosciences announces expected 2021 milestones\n$EVLO'
2021-01-07,"b'Evelo Biosciences expands clinical programs, provides 2021 priorities\n$EVLO'"
2021-01-07,b'$EVLO NEW ARTICLE : Evelo Biosciences Expands Clinical Programs and Provides 2021 Guidance on Key Milestones https://t.co/ene2lR7adt Get all the latest $EVLO related news here : https://t.co/nYpoxiddLV https://t.co/gBL0tVRmdB'
2021-01-07,"b'$EVLO [15s. delayed]: Issued Press Release on January 07, 07:00:00: Evelo Biosciences Expands Clinical Programs and Provides 2021 Guidance on Key Milestones https://t.co/EeUvTIDvYZ'"
2021-01-07,b'$EVLO Evelo Biosciences Expands Clinical Programs and Provides 2021 Guidance on Key Milestones\nhttps://t.co/lCxS0WyrK5'
2021-01-07,b'$evlo why you gotta be so thin?'
2021-01-06,b'$EVLO rejected here so many times. Can it break this time?'
2021-01-06,b'$EVLO cash runway short - pumped for offering IMO'
2021-01-06,b'$EVLO starting a short position above 11.5'
